Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
81.67M 96.63M 74.86M 54.92M
Cost of Revenue
33.79M 40.33M 31.47M 20.7M
Gross Profit
47.88M 56.3M 43.39M 34.22M
Operating Income
-46.73M -57.67M -66.21M -37.23M
Interest Income
2.51M 3.49M 777K 91K
Pretax Income
-55.22M -63.28M -70.52M -43.08M
Net Income
-55.37M -63.32M -70.64M -42.94M
Selling & General & Admin
69.32M 82.38M 79.65M 51.02M
Research & Development
19.75M 21.89M 23.21M 15.7M
Other Expenses
5.55M 9.7M 6.73M 4.73M
Operating Expenses
94.61M 113.97M 109.6M 71.44M
Interest Expense
10.43M 8.76M 4.55M 3.12M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
122.86M 154.3M 141.07M 92.14M
Income Tax Expense
146K 40K 123K -140K
Shares Outstanding (Basic)
49.42M 44.43M 37.75M 37.42M
Shares Outstanding (Diluted)
49.42M 44.43M 37.75M 37.42M
EPS (Basic)
-1.12 -1.43 -1.87 -1.15
EPS (Diluted)
-1.12 -1.43 -1.87 -1.15
EBITDA
-37.14M -45.63M -58.81M -35.17M
EBIT
-44.79M -54.52M -65.96M -39.96M
Depreciation & Amortization
7.65M 8.89M 7.15M 4.79M